Patents by Inventor Enrico Colli

Enrico Colli has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NEW MODIFIED RELEASE ORAL CONTRACEPTIVE COMPOSITION
    Publication number: 20240041775
    Abstract: The invention relates to a new modified release oral pharmaceutical form comprising 17?-cyanomethyl-17-?-hydrox-yestra-4,9-dien-3-one (dienogest) and 17a?-ethinylestradiol (ethynyl estradiol), its method of production and its medical and non-medical uses, in particular its use in contraception.
    Type: Application
    Filed: August 13, 2021
    Publication date: February 8, 2024
    Inventor: Enrico COLLI
  • Vaginal composition comprising a combination of estrogen and vitamin D
    Patent number: 11590145
    Abstract: The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 ?g to 100 ?g estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 ?g to 100 ?g of vitamin D equivalent.
    Type: Grant
    Filed: November 19, 2020
    Date of Patent: February 28, 2023
    Assignee: CHEMO RESEARCH S.L.
    Inventors: Enrico Colli, David F. Archer
  • VAGINAL COMPOSITION COMPRISING A COMBINATION OF ESTROGEN AND VITAMIN D
    Publication number: 20210069210
    Abstract: The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 ?g to 100 ?g estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 ?g to 100 ?g of vitamin D equivalent.
    Type: Application
    Filed: November 19, 2020
    Publication date: March 11, 2021
    Inventors: Enrico COLLI, David F. ARCHER
  • VAGINAL COMPOSITION COMPRISING A COMBINATION OF ESTROGEN AND VITAMIN D
    Publication number: 20190224213
    Abstract: The invention relates to vaginal composition comprising a combination of estrogen and vitamin D or a vitamin D analog at a daily dosage delivery of (i) estrogen ranging from 1 ?g to 100 ?g estrogen of estradiol equivalent and (ii) vitamin D or analog ranging from 7.5 ?g to 100 ?g of vitamin D equivalent.
    Type: Application
    Filed: July 20, 2017
    Publication date: July 25, 2019
    Applicant: Chemo Research S.L..
    Inventors: Enrico COLLI, David F. ARCHER
  • Darifenacin for use in the treatment of urgency induced by overactive bladder
    Patent number: 8748476
    Abstract: The invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the reduction of urgency in patients suffering from overactive bladder.
    Type: Grant
    Filed: March 4, 2009
    Date of Patent: June 10, 2014
    Assignee: Warner Chilcott Company, LLC
    Inventors: Enrico Colli, Paul Quinn, Dzelal Serdarevic, Larence Howard Skillern
  • NOVEL METHOD
    Publication number: 20100093675
    Abstract: There is provided a method of prevention of adhesions, eg surgical adhesions, which comprises using a vitamin D compound.
    Type: Application
    Filed: September 21, 2007
    Publication date: April 15, 2010
    Applicant: BIOXELL S.P.A.
    Inventors: Enrico Colli, Margherita Mariani, Paola Panina
  • NOVEL METHOD OF TREATMENT OF MALE SUB-FERTILITY
    Publication number: 20100069339
    Abstract: There is provided a method of treatment of male sub-fertility by using a vitamin D compound. Compositions and uses are also provided.
    Type: Application
    Filed: October 12, 2007
    Publication date: March 18, 2010
    Applicant: BIOXELL S.P.A.
    Inventors: Luciano Adorini, Giuseppe Penna, Enrico Colli
  • METHOD OF TREATMENT
    Publication number: 20090162433
    Abstract: The invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the reduction of urgency in patients suffering from overactive bladder.
    Type: Application
    Filed: March 4, 2009
    Publication date: June 25, 2009
    Inventors: Enrico Colli, Paul Quinn, Dzelal Serdarevic, Larence Howard Skillern
  • 20-Cyclopropyl, 26,27-Alkyl/Haloalkyl Vitamin D3 Compounds and Methods of Use Thereof
    Publication number: 20080318911
    Abstract: The invention provides vitamin D3 analogs of cholecalciferol, substituted at carbon 20 with cycloalkyl, e.g., cyclopropyl, wherein carbon-16 is a double bond, and carbon-23 is a single, double, or triple bond. Various alkyl or haloalkyl substitutions are incorporated as carbon-25. The invention provides pharmaceutically acceptable esters, salts, and prodrugs thereof. Methods for using the compounds to treat vitamin D3 associated states, and pharmaceutical compositions containing the compounds are also disclosed.
    Type: Application
    Filed: September 23, 2005
    Publication date: December 25, 2008
    Applicant: BIOXELL S.P.A.
    Inventors: Milan R. Uskokovic, Luciano Adorini, Guiseppe Penna, Enrico Colli, Stanislaw Marczak
  • Method for treating benign prostatic hyperplasia
    Publication number: 20080207769
    Abstract: The use of 1-alpha-fluoro-25-hydroxy-16,23E-diene-26,27-bishomo-20-epi-cholecalciferol, or a pharmaceutically acceptable salt or ester thereof, for the manufacture of a medicament for the prevention and/or treatment of benign prostatic hyperplasia (BPH) and associated symptoms.
    Type: Application
    Filed: October 24, 2007
    Publication date: August 28, 2008
    Applicant: BioXell S.p.A.
    Inventors: Luciano Adorini, Enrico Colli
  • 1,3-Diacylated, 26,27-Alkyl/Haloakyl Vitamin D3 Compounds and Methods of Use Thereof
    Publication number: 20080064668
    Abstract: The invention provides (1,3)di-acylated vitamin D3 analogs of cholecalciferol, substituted at carbon (20) with methyl or cyclopropyl wherein carbon (16) is a single or double bond, and carbon (23) is a single, double, or triple bond. Various alkyl or haloalkyl substitutions are incorporated at carbon (25). The invention provides pharmaceutically acceptable esters, salts, and pro-drugs thereof. Methods for using the compounds to treat vitamin D3 associated states, and pharmaceutical compositions containing the compounds are also disclosed.
    Type: Application
    Filed: September 24, 2004
    Publication date: March 13, 2008
    Applicant: BioXell S.p.A.
    Inventors: Milan R. Uskokovic, Luciano Adorini, Giuseppe Penna, Enrico Colli
  • Method for treating benign prostatic hyperplasia
    Patent number: 7332482
    Abstract: The use of 1-alpha-fluoro-25-hydroxy-16,23E-diene-26,27-bishomo-20-epi-cholecalciferol, or a pharmaceutically acceptable salt or ester thereof, for the manufacture of a medicament for the prevention and/or treatment of benign prostatic hyperplasia (BPH) and associated symptoms.
    Type: Grant
    Filed: July 29, 2004
    Date of Patent: February 19, 2008
    Assignee: BioXell S.p.A.
    Inventors: Luciano Adorini, Enrico Colli
  • Treatment of Interstitial Cystitis with Vitamin D Compounds
    Publication number: 20080039434
    Abstract: There is provided according to the invention a vitamin D compound for use in the prevention and/or treatment of interstitial cystitis. Also provided is a method for preventing and/or treating interstitial cystitis by administering an effective amount of a vitamin D compound.
    Type: Application
    Filed: March 1, 2005
    Publication date: February 14, 2008
    Applicant: BioXell S. p.A.
    Inventor: Enrico Colli
  • Method of treatment
    Publication number: 20070264333
    Abstract: The invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the reduction of urgency in patients suffering from overactive bladder.
    Type: Application
    Filed: July 19, 2007
    Publication date: November 15, 2007
    Inventors: Enrico Colli, Paul Quinn, Dzelal Serdarevic, Larence Howard Skillern
  • Methods for treating bladder dysfunction
    Publication number: 20070054887
    Abstract: There is provided according to the invention the use of Vitamin D compounds such as 1-alpha-fluoro-25-hydroxy-16,23e-diene-26,27-bishomo-20-epi-cholecalciferol in the prevention or treatment of bladder dysfunction.
    Type: Application
    Filed: September 24, 2004
    Publication date: March 8, 2007
    Applicant: BioXell S.p.A
    Inventor: Enrico Colli
  • Method for treating benign prostatic hyperplasia
    Publication number: 20050065124
    Abstract: The use of 1-alpha-fluoro-25-hydroxy-16,23E-diene-26,27-bishomo-20-epi-cholecalciferol, or a pharmaceutically acceptable salt or ester thereof, for the manufacture of a medicament for the prevention and/or treatment of benign prostatic hyperplasia (BPH) and associated symptoms.
    Type: Application
    Filed: July 29, 2004
    Publication date: March 24, 2005
    Inventors: Luciano Adorini, Enrico Colli
  • Method of treatment
    Publication number: 20030130338
    Abstract: The invention provides the use of darifenacin, or a pharmaceutically acceptable derivative thereof, in the manufacture of a medicament for the reduction of urgency in patients suffering from overactive bladder.
    Type: Application
    Filed: September 26, 2002
    Publication date: July 10, 2003
    Inventors: Enrico Colli, Paul Quinn, Dzelal Serdarevic, Larence Howard Skillern